Featured News

In JAMA psychiatry, researchers outline new theories connecting antipsychotic use in people with schizophrenia and increased dementia risk.

MIA’s Ayurdhi Dhar interviews Sunil Bhatia about decolonizing psychology, confronting the field’s racist past, colonial foundations, and neoliberal present.

A new study finds that newborn babies experience antidepressant withdrawal after birth if their mothers take SSRIs when pregnant.

Research suggests that slowly tapering off an antipsychotic reduces the risk of withdrawal psychosis compared to abrupt discontinuation.

A new study published in JAMA Psychiatry connects antipsychotics with damage to the brain in multiple areas.

Evolutionary theorists suggest that antidepressants interfere with the adaptive function of depression and propose a test of this theory.

Hanna Pickard on the elusive middle ground between personal responsibility and systemic factors in our understandings of addiction.

Research finds that social cognition and emotional processing abilities can be disrupted by psychiatric drugs.

A new study investigates how antidepressant withdrawal effects often get confounded with depression relapse in clinical trials.

MIA’s Ayurdhi Dhar interviews Ian Parker about critical psychology, discourse and political action, and whether psychology has anything left to offer.

The FDA collaborated with Biogen to conduct repeated re-analyses of aducanumab for Alzheimer's and FDA committee members are raising concerns.

In the first systematic review of withdrawal problems that patients experience when trying to get off SSRI antidepressant medications, researchers found that withdrawing from SSRIs was comparable to trying to quit addictive benzodiazepines.

A new article in Lancet Psychiatry debunks past studies claiming that those on low doses of antipsychotics are more likely to relapse.

People with "serious mental illness" who stop taking antipsychotics are more likely to recover, even when accounting for baseline severity.

New study finds that people who felt they were coerced into being hospitalized were more likely to attempt suicide later.

A new study, published in the JAMA Psychiatry, investigates the effect of stimulant ‘ADHD’ drugs on the brains of children and young adults. The...

Medical researchers present evidence that ADHD is overdiagnosed in children and teens, which can lead to significant harm.

A study of over 1.5 million people in Europe and the US links the development of less adaptive personalities with childhood lead exposure.

Robin Williams had "therapeutic" levels of the tetra-cyclic antidepressant mirtazapine in his blood at the time of his suicide, according to the coroner's report...

The alternative treatment model of Soteria helps individuals suffering from schizophrenia without relying on medication or coercion.

A large study of the population in Taiwan reveals that long-term use of benzodiazepine drugs, commonly prescribed for anxiety, significantly increases the risk for brain, colorectal, and lung cancers. The research, published open-access in the journal Medicine, also identifies the types of benzodiazepines that carry the greatest cancer risk.

An analysis of FDA adverse event reports related to esketamine shows the potential for negative effects such as suicidal and self-injurious ideation.

The CHR-P model focuses on “attenuated psychosis” to predict “transition” to schizophrenia and ignores other factors. But new research shows that the model is a poor predictor.

MIA’s Hannah Emerson interviews Comas-Díaz on the need for culturally competent care in a medicalized and individualistic society.

MIA’s Justin Karter interviews critical psychiatrist and philosopher Pat Bracken about the necessity of challenging received wisdom.